1. Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab. Issue 6 (28th May 2013) Authors: Matucci, A.; Pratesi, S.; Petroni, G.; Nencini, F.; Virgili, G.; Milla, M.; Maggi, E.; Vultaggio, A. Journal: Clinical & experimental allergy Issue: Volume 43:Issue 6(2013:Jun.) Page Start: 659 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Circulating T cells to infliximab are detectable mainly in treated patients developing anti‐drug antibodies and hypersensitivity reactions. (26th October 2016) Authors: Vultaggio, A.; Petroni, G.; Pratesi, S.; Nencini, F.; Cammelli, D.; Milla, M.; Prignano, F.; Annese, V.; Romagnani, S.; Maggi, E.; Matucci, A. Journal: Clinical and experimental immunology Issue: Volume 186:Number 3(2016:Dec.) Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Issue 7 (24th April 2015) Authors: Boyman, O.; Kaegi, C.; Akdis, M.; Bavbek, S.; Bossios, A.; Chatzipetrou, A.; Eiwegger, T.; Firinu, D.; Harr, T.; Knol, E.; Matucci, A.; Palomares, O.; Schmidt‐Weber, C.; Simon, H.‐U.; Steiner, U. C.; Vultaggio, A.; Akdis, C. A.; Spertini, F. Journal: Allergy Issue: Volume 70:Issue 7(2015:Jul.) Page Start: 727 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effects of omalizumab in severe asthmatics across ages: A real life Italian experience. (October 2016) Authors: Sposato, B.; Scalese, M.; Latorre, M.; Scichilone, N.; Matucci, A.; Milanese, M.; Masieri, S.; Rolla, G.; Steinhilber, G.; Rosati, Y.; Vultaggio, A.; Folletti, I.; Baglioni, S.; Bargagli, E.; Di Tomassi, M.; Pio, R.; Pio, A.; Maccari, U.; Maggiorelli, C.; Migliorini, M.G. Journal: Respiratory medicine Issue: Volume 119(2016) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effects of omalizumab in severe asthmatics across ages: A real life Italian experience. (October 2016) Authors: Sposato, B.; Scalese, M.; Latorre, M.; Scichilone, N.; Matucci, A.; Milanese, M.; Masieri, S.; Rolla, G.; Steinhilber, G.; Rosati, Y.; Vultaggio, A.; Folletti, I.; Baglioni, S.; Bargagli, E.; Di Tomassi, M.; Pio, R.; Pio, A.; Maccari, U.; Maggiorelli, C.; Migliorini, M.G. Journal: Respiratory medicine Issue: Volume 119(2016) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IgG4 anti‐infliximab in treated patients: Clinical impact and temporal evolution. Issue 11 (2nd October 2018) Authors: Vultaggio, A.; Nencini, F.; Carraresi, A.; Pratesi, S.; Movérare, R.; Eriksson, C.; Venemalm, L.; Maggi, E.; Matucci, A. Journal: Allergy Issue: Volume 73:Issue 11(2018) Page Start: 2172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immunoglobulin replacement therapy for yellow nail syndrome. (10th January 2018) Authors: Lo Conte, C.; Allegrini, C.; Matucci, A.; Bartolucci, M.; Rosi, E.; Camiciottoli, G.; Amendola, M.; Pistolesi, M.; Bargagli, E. Journal: Scandinavian journal of immunology Issue: Volume 87:Number 3(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0129 Incidence and clinical outcome of anti-drug antibodies in infliximab-treated patients. (23rd January 2014) Authors: Bartoli, F.; Fiori, G.; Galluccio, F.; Petroni, G.; Pratesi, S.; Matucci, A.; Vultaggio, A.; Nacci, F.; Nencini, F.; Maggi, E.; Matucci-Cerinic, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group. (25th August 2017) Authors: Jolles, S.; Sánchez‐Ramón, S.; Quinti, I.; Soler‐Palacín, P.; Agostini, C.; Florkin, B.; Couderc, L.‐J.; Brodszki, N.; Jones, A.; Longhurst, H.; Warnatz, K.; Haerynck, F.; Matucci, A.; de Vries, E. Journal: Clinical and experimental immunology Issue: Volume 190:Number 2(2017:Nov.) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗